Items Tagged ‘Mark Stegall’
December 23, 2019 · Leave a Comment
Teaching a computer to read a kidney biopsy
By Advancing the Science contributor 
Mayo researchers say patients will benefit from faster, more accurate reads By Jay Furst Artificial intelligence may never replace human insight, expertise and judgment. Then again, no one’s complaining about how it can help, especially when it comes to analyzing kidney biopsies, a laborious process that’s an intricate mix of art and science. Accurate and […]
View full entry Comment on this
Tags: Aleksandar Denic, artificial intelligence, Byron Smith, collaboration, kidney disease, kidney transplant, Mariam Priya Alexander, Mark Stegall, nephrology, pathology, team science, transplant
August 10, 2017 · Leave a Comment
TOGETHER TRIAL–An individualized strategy for stopping organ rejection
By Advancing the Science contributor
Mayo Clinic’s Center for Individualized Medicine is collaborating with a molecular diagnostics company to monitor patients after an organ transplant and improve the efficacy of immunosuppressant drugs by tailoring treatment to an individual’s genome. The effectiveness of immunosuppressant drugs is governed by a number of factors, but a major contributor is an individual’s genome. The […]
View full entry Comment on this
Tags: Alexander Parker, Center for Individualized Medicine, clinical trials, Individualizing Medicine Conference, kidney transplant, Mark Stegall, transplant
May 9, 2017 · Leave a Comment
Increasing the Odds Mayo Clinic performs more transplants than any other organization in the country. That experience allows Mayo Clinic scientist-physicians to study stem cells and personalize drugs to fight organ rejection and increase the number of viable lungs. Immune-Building Stem Cell Research In the 1970s, when Cesar A. Keller, M.D., started his career in […]
View full entry Comment on this
Tags: Alexander Parker, Center for Individualized Medicine, Center for Regenerative Medicine, Cesar Kellar, genetic testing, kidney transplant, lung transplant, Mark Stegall, personalized medicine, regenerative medicine, stem cells, transplant